SHAPE & BRUSSELS
SHAPE and Brussels Medical Centre
We provide a full spectrum GP service in conjunction with Belgian, Defence and NHS specialists. Our clinical staff also visit Brussels for clinics and provide support to the Central European Practice. The facility leaflet is at the tab below.
Get in touch
SHAPE eConsult – Contact the practice with your admin or clinical query
Meet the Team
Mrs E Fuller
Senior Medical Officer
Lt Col N MacLeod
GP – CMP
Dr A Ure
Mrs J Paterson
Mrs V Lack
Mrs K Riley
Capt P Gimson
Sgt W Benza-Chofur
Patient Support Cell
Mme C Bausier
Mme D Dochot
Mrs J Cauldwell
Mrs E McAulay
Mrs E Owusu
SHAPE Healthcare Facility – UK Clinic Building 401, Rue D’Oslo, SHAPE, 7010 Maisieres, Belgium
Patient support and referrals: +32 (0)65 44 2071
Dispensary: +32 (0)65 44 5999
Practice: UKStratCom-DMS-DPHC-MON-Grp@mod.gov.uk +32 (0)65 44 5824
Patient support: UKStratCom-DMS-DPHC-MON-PatSpGrp@mod.gov.uk +32 (0)65 65 44 5824
Healix: +44 (0) 208 4817800 email@example.com
Monday – Thursday: 0800 – 1700 & Friday 0900 – 1530
US facility including labs and x-ray 0800 – 1130 & 1300 – 1530 (closed for training 3rd Thurs morning each month)
SHAPE: The healthcare facility is near the main shopping car park. For the UK section go through the main entrance then follow signs for ‘London’.
Brussels. If you are coming to the Sterrebeek site we will pre-arrange your entry and you will require your passport. You can also apply for an ‘installation card’ through your NSE.
JF Kennedylaan 12, 1933 Sterrebeek
Reception: +32 (0)2 686 1515
Brussels UK clinics: Fridays and by arrangement
Symptoms which may be COVID-19 or +ve test – what should I do?
UK update Jan 2022
Isolate in accordance with current national and base rules.
2. CONSULT UK MEDICS
DO NOT attend a facility in person. Make a phone appointment with your UK healthcare provider. (+32 6544 5824 or UKStratCom-DMS-DPHC-MON-Grp@mod.gov.uk). You will be placed on a COVID clinic for a call-back and to plan testing +/- assessment.
There are various options for testing now. This includes: UK-organised, SHAPE drivethru (for mild symptoms that do not require medical assessment) or testing in the HN. Please DO let us know if you test +ve in the NHS or NATO/US system (for instance as a contact or while on leave) having bypassed the UK clinic.
Out of hours. If you have mild symptoms (or none) email us or call the next working day. Only if you need more urgent advice call our colleagues at HEALIX on+44 208 4817800. They will direct you to a route of assessment and/or let us know. If you are urgently unwell attend A and E or call 112.
Results. If a test is taken for symptoms in SHAPE you should expect a result between 24 and 72 hours, called through by one of the UK clinicians or the Prev med team depending on who organised it. Symptomatic results are prioritised and are usually within 24 hours but may take a little longer if the on-site lab is busy.
3. TRACE AND MONITOR
The HN authorities may call and advise on measures outside your base if you have tested positive on an external test (Rapid antigen or PCR).
SHAPE orders directed those on base to call the Prev Med team to initiate contact tracing and obtain direction on SHAPE measures: +32 65 325336. This number may not be monitored constantly so please await a response to your voicemail if there is no answer.
Those working in Brussels should follow local guidance and direction. Please also note that actions on NATO or military establishments may differ from current UK or Belgian measures.
4. INFORM UNIT
You are requested to notify your line manager and your NSE of your absence (or WFH). There is a reporting form on EJSU.net if you prefer this method. They may ask you to identify your movements prior to having symptoms to allow them to work with Prev Med or contact tracing should you test positive or they may refer you direct to the local contact tracing procedure. Out of hours emergencies. European Duty Field Officer on +32 479 911075
Belgian COVID info: https://www.info-coronavirus.be/en/quarantine-isolation/
NHS COVID info: https://www.nhs.uk/conditions/coronavirus-covid-19/
SHAPE drivethru test booking: https://shapecovidtesting.as.me/schedule.php
Host Nation testing (needs COVIDsafe.be activated: https://sat.info-coronavirus.be/fr/formulaire/sat *Please ensure you have medical authorisation for a HN test or you will be liable for the bill yourself if it is charged.
EJSU NSE reporting form: https://www.ejsu.net/covid19-reporting/
SHAPE contact tracing and COVID info: https://www.shape2day.com/
COVID Immunisation SHAPE – UK Update Jan 22
The details of any immunisation undertaken in the host nation (including type, batch number and date of expiry) should be sent to your practice so we can update your NHS and Defence records.
Anyone who is eligible and wishes to start or complete a primary course of COVID vaccine may make an appointment with the UK med centre or take up the Belgian offer.
Third primary doses
A very small number of people in the UK MoD population required a third primary dose of vaccine due to having a condition or taking medicines that affect the immune response. This third dose used an mRNA vaccine. If you are in this group you should note that you will also be offered a booster (4th dose) three months from your third dose.
All those over 16 who are more than 3 months from their primary course of COVID immunisation are eligible for a booster dose of one of the mRNA vaccines (Moderna/Pfizer).
In addition the UK’s Joint Committee on Vaccination and Immunisation (JCVI) has advised that booster vaccinations should be offered to persons aged:
• 12 to 15 who are in a clinical risk group or who are a household contact of someone (of any age) who is immunosuppressed
• 12 to 15 years who are severely immunocompromised and who have had a third primary dose
All adults should now have been offered a COVID booster at a DPHC clinic, in the host nation or in the UK. Please email the practice if you have experienced any problems with access.
The UK advisors (JCVI) now advise (here) that those aged 12-17 may be offered two doses of the Pfizer BioNTech (Comirnaty) vaccine. Young people over 16 at greater risk of serious illness if they catch COVID-19 will need 2 doses of vaccine, 8 weeks apart and all other young people will be offered 2 doses of vaccine 12 weeks apart.
The Belgian healthcare system has been offering two doses of Pfizer at a minimum of a 3 week interval since last Autumn and many children have taken up this offer already.
UK: Following extensive assessment of the risks and benefits of vaccinations for 5 to 11 year olds, including analysis of clinical trial results and real-world international data, the JCVI has updated its advice for this age group:
In the UK, children aged 5 to 11, who are in a clinical risk group or who are a household contact of someone (of any age) who is immunosuppressed, should be offered a primary course of vaccination. This is with 2 x 10-microgram doses of the Pfizer-BioNTech COVID-19 vaccine (a third of the adult dose), with an interval of 8 weeks between the first and second doses.
Further advice regarding COVID-19 vaccination for other 5 to 11 year olds will be issued in the UK in due course following consideration of additional data relevant to this age group, and on the Omicron variant more broadly.
Host Nation offers
In Belgium and many other countries in Europe there is already an offer to the parents of children in the 5-11 age group. The primary course of vaccination for all in this age-group is also with a third of the adult dose of Pfizer vaccine, but with an interval in Belgium of at least 3 weeks between the first and second doses.
Like the UK, European nations found their decisions on child immunisation on extensive assessment of the risks and benefits by the European Medicines Agency (EMA) and national health authorities. We have seen throughout the pandemic that aspects of the immunisation program and response to COVID differ.
Individual preferences; the host nation offer; and the residency and registration status of the child will all play a part in family decisions on whether to take up an offer in your country of residence.
MoD position: JSP 950, Leaflet 7-1-1 (linked on ModNet here): So long as the HN-provided vaccine is compliant with the EMA/FDA/MHRA conditions of authorisation an individual (or the person with parental responsibility) can accept the offer of a HN vaccine under the principles of informed consent (noting that children aged 16-17 are often competent to give their own consent).
In making your decisions, it is also worth highlighting that MoD staff have no authority to move ahead of the NHS program so your medical centre cannot, for instance, offer immunisations in line with the Belgian program.
We understand that differing approaches to immunisation and certification between the UK and other nations creates challenges for those who live or travel between two regions (in particular children who are at school in the UK). This has broadly been resolved for over 12s since the UK decision to offer these children 2 doses.
Please email the practice if the inability to obtain immunisation for 5-11 year olds in the UK affects their ability to travel to you or attend school.
Certification – Children
Fully vaccinated 12 to 15 year olds are now able to access a NHS COVID Pass letter for travel including an internationally recognised 2D barcode. The COVID Pass letter is valid for 30 days and may take 7- 14 working days to be delivered. It can be ordered by calling 119 or 0300 311 22 33 or via the website NHS.UK.
Obtaining COVIDsafe.be app in Belgium is an advantage for those who have obtained immunisation in the HN.
Certification – over 16
To download an NHS certificate of vaccination you may create an NHS online logon at https://www.coronavirus-record.service.nhs.uk .
The certificate may then be downloaded at https://covid-status.service.nhsx.nhs.uk/
· This is NOT the App
· Use a personal device with camera access.
· You will be asked to validate the account with a form of British ID
· If asked for a postcode, use the BFPO equivalent postcode BF1 2AG
· You will need to re-download a new code each 30 days.